WeVote

Bill

Bill

LD 107

An Act To Require Health Insurance Coverage For Biomarker Testing

132nd Legislature (2025-2026) Introduced by Amy Arata and 7 co-sponsors

Maine bill mandates health insurance coverage for biomarker testing to improve disease detection, now pending budget review before final enactment.

Died in Possession of the Senate when the Legislature adjourned Sine Die and was PLACED IN THE LEGISLATIVE FILES. (DEAD)
0
WeVote Research Nonpartisan
Bill Summary · LD 107

Legislative bill overview

LD 107 requires health insurance plans in Maine to cover biomarker testing—diagnostic tests that identify biological markers indicating disease risk, presence, or prognosis. The bill passed both chambers and was placed on the Special Appropriations Table, meaning it requires budget review before final enactment due to potential state fiscal impacts.

Why is this important

Biomarker testing can enable early disease detection and personalized treatment decisions, potentially improving health outcomes and reducing long-term medical costs. However, mandating insurance coverage creates new financial obligations for insurers and may affect premium costs, making this a healthcare access versus affordability tradeoff with real budgetary consequences for the state.

Potential points of contention

  • Coverage scope ambiguity: The bill may lack specificity about which biomarker tests qualify, potentially leading to disputes over experimental versus proven diagnostics and disputes between insurers and patients
  • Cost implications: Health insurance mandates typically increase premiums; the Special Appropriations Table placement indicates fiscal concerns about state employee health plans and potential insurance market effects
  • Medical necessity standards: Disagreement over whether biomarker testing should be required for all patients or only those meeting specific clinical criteria could affect both access and costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.